Ozempic Blood Clot Side Effects Ozempic may have serious blood clot side effects, including deep vein thrombosis (DVT) and pulmonary embolism (PE)
Pre-Approval Clinical Trial Data The clinical trials that led to FDA approval showed: High rates of nausea, vomiting, and abdominal pain among participants Documented cases of severe gastrointestinal issues requiring medical treatment Evidence that slowed gastric emptying persisted in some patients Reports of adverse event reports related to digestive system paralysis Despite this significant evidence from clinical trials, Novo Nordisks labeling focused on common, temporary side effects while failing to warn patients about the risk of permanent gastroparesis
Severe gastrointestinal disease, particularly gastroparesis or other conditions causing significant delays in gastric emptying, may be exacerbated by treatment with Semaglutide / Cyanocobalamin Injection
If you are paying cash pay through a manufacturer program or telehealth platform, prior authorization is not required
If you believe this is an error, please contact support.
